Securities code: 600521 securities abbreviation: Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) Announcement No.: Lin 2022-003 bond Code: 110076 bond abbreviation: Huahai convertible bond
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521)
Announcement of convertible bond conversion results and share changes
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
Share conversion: Huahai convertible bonds began to be converted on May 6, 2021. As of December 31, 2021, a total of 98000 yuan of Huahai convertible bonds had been converted into shares of the company. The number of shares formed by share conversion was 2831 shares, accounting for 0.0002% of the total issued shares of the company before Huahai convertible bonds were converted into shares.
Situation of convertible bonds not converted into shares: as of December 31, 2021, the amount of Huahai convertible bonds not converted into shares was 1842502000 yuan, accounting for 99.9947% of the total issuance of Huahai convertible bonds.
1、 Overview of convertible bond issuance and listing
(i) Issuance and listing of Huahai convertible bonds
With the approval of zjxk [2020] No. 2261 document of China Securities Regulatory Commission, Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) (hereinafter referred to as "the company") publicly issued 18.426 million convertible corporate bonds on November 2, 2020, with a face value of 100 yuan each and a total issuance amount of 1842.6 million yuan, with a term of 6 years from the date of issuance. With the consent of self regulatory decision [2020] No. 376 of Shanghai Stock Exchange, the company's 1842.6 million yuan convertible corporate bonds were listed and traded in Shanghai Stock Exchange on November 25, 2020. The bonds are referred to as "Huahai convertible bonds" for short and the bond code is "110076".
（2） Term and price of Huahai convertible bonds
According to the provisions of the prospectus for public offering of convertible corporate bonds and relevant laws and regulations, the Huahai convertible bonds issued by the company can be converted into shares of the company from May 6, 2021. The conversion period is until November 1, 2026, and the initial conversion price is 34.66 yuan / share.
In June 2021, due to the company's profit distribution in 2020, the conversion price of Huahai convertible bonds was adjusted from 34.66 yuan / share
The whole is 34.46 yuan / share, and the adjusted share conversion price will take effect from June 11, 2021. For details, please refer to China Securities Journal, Shanghai Securities News, securities times, securities daily and the website of Shanghai Stock Exchange on June 4, 2021 com.. cn. The Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) suggestive announcement on the adjustment of the conversion price of "Huahai convertible bonds" (Announcement No.: Lin 2021-051).
In July 2021, due to the company's implementation of the restricted stock incentive plan, 37145000 restricted shares were added. Therefore, the conversion price of Huahai convertible bonds was adjusted from 34.46 yuan / share to 33.85 yuan / share. The adjusted conversion price will take effect from July 13, 2021. For details, please refer to China Securities Journal, Shanghai Securities News, securities times, securities daily and the website of Shanghai Stock Exchange on July 9, 2021 com.. cn. Announcement of Zhejiang Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) Co., Ltd. on granting restricted shares and issuing additional shares to adjust the conversion price of convertible bonds (Announcement No.: Lin 2021-065).
2、 This share conversion of Huahai convertible bonds
From October 1, 2021 to December 31, 2021, a total of 3000 yuan of Huahai convertible bonds were converted into shares of the company. The number of shares formed by the conversion was 87 shares, accounting for 0.000006% of the total issued shares of the company before Huahai convertible bonds were converted into shares.
As of December 31, 2021, a total of 98000 yuan of Huahai convertible bonds had been converted into shares of the company. The number of shares formed by the conversion was 2831 shares, accounting for 0.0002% of the total issued shares of the company before Huahai convertible bonds were converted into shares; The amount of Huahai convertible bonds that have not been converted into shares is 1842502000 yuan, accounting for 99.9947% of the total issuance of Huahai convertible bonds.
3、 Changes in shares
Unit: shares
Before the change of share class and after the change of Huahai convertible bonds
(September 30, 2021) number of shares converted (December 31, 2021)
Non tradable shares 1454610791871454610878
Tradable shares with limited sales conditions 37145000 37145000
Total 1491755791871491755878
4、 Contact information
Contact: Jin min, Wang Huiting
Tel.: 0576-85015699
Contact Fax: 0576-85016010
It is hereby announced.
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) board of directors
January 3, 2022
